New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas.
The studies, published Dec. 10 in Nature Immunology and Oct. 1 in Cancer Discovery, showed that one of the proteins, LSD1, plays a major role in starting and sustaining lymphomas, while the other, TET2, normally prevents lymphomas from developing. The discoveries point to the possibility of new lymphoma...